| Drug repurposing in oncology—patient and health systems opportunities F Bertolini, VP Sukhatme, G Bouche Nature reviews Clinical oncology 12 (12), 732-742, 2015 | 290 | 2015 |
| Repurposing drugs in oncology (ReDO)—Cimetidine as an anti-cancer agent P Pantziarka, G Bouche, L Meheus, V Sukhatme, VP Sukhatme ecancermedicalscience 8, 2014 | 288 | 2014 |
| Repurposing Drugs in Oncology (ReDO)—chloroquine and hydroxychloroquine as anti-cancer agents C Verbaanderd, H Maes, MB Schaaf, VP Sukhatme, P Pantziarka, ... ecancermedicalscience 11, 2017 | 238 | 2017 |
| Does the risk of compressive hematoma after thyroidectomy authorize 1-day surgery? P Leyre, T Desurmont, L Lacoste, C Odasso, G Bouche, A Beaulieu, ... Langenbeck's archives of surgery 393, 733-737, 2008 | 158 | 2008 |
| Repurposing Drugs in Oncology (ReDO)—diclofenac as an anti-cancer agent P Pantziarka, V Sukhatme, G Bouche, L Meheus, VP Sukhatme Ecancermedicalscience 10, 2016 | 134 | 2016 |
| Repurposing Drugs in Oncology (ReDO)—mebendazole as an anti-cancer agent P Pantziarka, G Bouche, L Meheus, V Sukhatme, VP Sukhatme ecancermedicalscience 8, 2014 | 113 | 2014 |
| Repurposing Drugs in Oncology (ReDO)—Propranolol as an anti-cancer agent P Pantziarka, G Bouche, V Sukhatme, L Meheus, I Rooman, VP Sukhatme ecancermedicalscience 10, 2016 | 107 | 2016 |
| ReDO_DB: the repurposing drugs in oncology database P Pantziarka, C Verbaanderd, V Sukhatme, IR Capistrano, S Crispino, ... ecancermedicalscience 12, 2018 | 103 | 2018 |
| Parental use of the Internet to seek health information and primary care utilisation for their child: a cross-sectional study G Bouche, V Migeot BMC public health 8, 1-9, 2008 | 93 | 2008 |
| Sleep disorders and multiple sclerosis: a clinical and polysomnography study JP Neau, J Paquereau, V Auche, S Mathis, G Godeneche, J Ciron, ... European neurology 68 (1), 8-15, 2012 | 87 | 2012 |
| Appraisal of the knowledge of hypertensive patients and assessment of the role of the pharmacists in the management of hypertension: results of a regional survey S Ragot, P Sosner, G Bouche, J Guillemain, D Herpin Journal of human hypertension 19 (7), 577-584, 2005 | 84 | 2005 |
| Repurposing Drugs in Oncology (ReDO)—itraconazole as an anti-cancer agent P Pantziarka, V Sukhatme, G Bouche, L Meheus, VP Sukhatme Ecancermedicalscience 9, 2015 | 81 | 2015 |
| Repurposing Drugs in Oncology (ReDO)—clarithromycin as an anti-cancer agent AMT Van Nuffel, V Sukhatme, P Pantziarka, L Meheus, VP Sukhatme, ... ecancermedicalscience 9, 2015 | 81 | 2015 |
| Restless legs syndrome and pregnancy: a questionnaire study in the Poitiers District, France JP Neau, A Porcheron, S Mathis, A Julian, JC Meurice, J Paquereau, ... European neurology 64 (5), 268-274, 2010 | 66 | 2010 |
| Repurposing drugs in your medicine cabinet: untapped opportunities for cancer therapy? P Pantziarka, G Bouche, L Meheus, V Sukhatme, VP Sukhatme Future oncology 11 (2), 181-184, 2015 | 53 | 2015 |
| Repurposing drugs in oncology: From candidate selection to clinical adoption P Pantziarka, C Verbaanderd, I Huys, G Bouche, L Meheus Seminars in Cancer Biology 68, 186-191, 2021 | 50 | 2021 |
| Repurposing drugs in oncology (ReDO)—selective PDE5 inhibitors as anti-cancer agents P Pantziarka, V Sukhatme, S Crispino, G Bouche, L Meheus, ... ecancermedicalscience 12, 2018 | 50 | 2018 |
| Usefulness of the short IQCODE for predicting postoperative delirium in elderly patients undergoing hip and knee replacement surgery M Priner, M Jourdain, G Bouche, I Merlet-Chicoine, JA Chaumier, ... Gerontology 54 (2), 116-119, 2008 | 43 | 2008 |
| A phase Ib/IIa trial of 9 repurposed drugs combined with temozolomide for the treatment of recurrent glioblastoma: CUSP9v3 ME Halatsch, RE Kast, G Karpel-Massler, B Mayer, O Zolk, B Schmitz, ... Neuro-Oncology Advances 3 (1), vdab075, 2021 | 40 | 2021 |
| Repurposing Drugs in Oncology (ReDO)—Nitroglycerin as an anti-cancer agent V Sukhatme, G Bouche, L Meheus, VP Sukhatme, P Pantziarka Ecancermedicalscience 9, 2015 | 39 | 2015 |
